Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zoli

Showing results (221-230 of 261) with videos related to

Pageof 27
Sort By:
Journal of Endocrinological Investigation|March 28, 2020
Results and predictors of outcome of endoscopic endonasal surgery in Cushing's disease: 20-year experience of an Italian referral Pituitary CenterF Guaraldi, M Zoli, S Asioli, et al.
Nature|January 15, 1998
Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotineM R Picciotto, M Zoli, R Rimondini, et al.
Acta Physiologica Scandinavica|September 1, 1985
Effects of ganglioside GM1 treatment on striatal glucose metabolism, blood flow, and protein phosphorylation of the ratL F Agnati, K Fuxe, F Benfenati, et al.
International Journal of Clinical Practice|October 30, 2013
A comparison of risk factors as predictors of cardiovascular and non-cardiovascular mortality in the elderly people--relevance of N-terminal pro-B-type natriuretic peptide and low systolic blood pressureA Muscari, G Bianchi, P Forti, et al.
Journal of Hepatology|February 1, 1994
Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferationG Ballardini, P Groff, M Zoli, et al.
Neuropharmacology|May 10, 2016
In vivo chronic nicotine exposure differentially and reversibly affects upregulation and stoichiometry of α4β2 nicotinic receptors in cortex and thalamusF Fasoli, M Moretti, M Zoli, et al.
Acta Physiologica Scandinavica|August 1, 1985
Effects of lesions and ganglioside GM1 treatment on striatal polyamine levels and nigral DA neurons. A role of putrescine in the neurotropic activity of gangliosidesL F Agnati, K Fuxe, I Zini, et al.
Italian Journal of Neurological Sciences|June 1, 1991
A new model of focal brain ischemia based on the intracerebral injection of endothelin-1L F Agnati, M Zoli, M Kurosawa, et al.
Progress in Brain Research|January 1, 1986
Studies on peptide comodulator transmission. New perspective on the treatment of disorders of the central nervous systemK Fuxe, L F Agnati, A Härfstrand, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Neuropeptide Y and central cardiovascular regulation. Focus on its role as a cotransmitter in cardiovascular adrenergic neuronsK Fuxe, J A Aguirre, L F Agnati, et al.
Pageof 27

Showing results (221-230 of 261) with videos related to

Sort By:
Pageof 27
Journal of Endocrinological Investigation|March 28, 2020
Results and predictors of outcome of endoscopic endonasal surgery in Cushing's disease: 20-year experience of an Italian referral Pituitary CenterF Guaraldi, M Zoli, S Asioli, et al.
Nature|January 15, 1998
Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotineM R Picciotto, M Zoli, R Rimondini, et al.
Acta Physiologica Scandinavica|September 1, 1985
Effects of ganglioside GM1 treatment on striatal glucose metabolism, blood flow, and protein phosphorylation of the ratL F Agnati, K Fuxe, F Benfenati, et al.
International Journal of Clinical Practice|October 30, 2013
A comparison of risk factors as predictors of cardiovascular and non-cardiovascular mortality in the elderly people--relevance of N-terminal pro-B-type natriuretic peptide and low systolic blood pressureA Muscari, G Bianchi, P Forti, et al.
Journal of Hepatology|February 1, 1994
Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferationG Ballardini, P Groff, M Zoli, et al.
Neuropharmacology|May 10, 2016
In vivo chronic nicotine exposure differentially and reversibly affects upregulation and stoichiometry of α4β2 nicotinic receptors in cortex and thalamusF Fasoli, M Moretti, M Zoli, et al.
Acta Physiologica Scandinavica|August 1, 1985
Effects of lesions and ganglioside GM1 treatment on striatal polyamine levels and nigral DA neurons. A role of putrescine in the neurotropic activity of gangliosidesL F Agnati, K Fuxe, I Zini, et al.
Italian Journal of Neurological Sciences|June 1, 1991
A new model of focal brain ischemia based on the intracerebral injection of endothelin-1L F Agnati, M Zoli, M Kurosawa, et al.
Progress in Brain Research|January 1, 1986
Studies on peptide comodulator transmission. New perspective on the treatment of disorders of the central nervous systemK Fuxe, L F Agnati, A Härfstrand, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Neuropeptide Y and central cardiovascular regulation. Focus on its role as a cotransmitter in cardiovascular adrenergic neuronsK Fuxe, J A Aguirre, L F Agnati, et al.
Pageof 27